enGene Holdings Inc. Common Stock • ENGN

Capital at risk.

About enGene Holdings Inc. Common Stock
Ticker
info
ENGN
Trading on
info
NASDAQ
ISIN
info
CA29286M1059
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Ronald H. W. Cooper
Headquarters
info
4868 Rue Levy, Montreal, QC, Canada, H4R 2P1
Employees
info
81
Website
info
engene.com
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
Metrics
BasicAdvanced
Market cap
info
$618M
P/E ratio
info
-
EPS
info
-$2.29
Dividend Yield
info
0.00%
Beta
info
-0.28
Forward P/E ratio
info
0
EBIDTA
info
$-123M
Ex dividend date
info
-
Price & volume
Market cap
info
$618M
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
3.63
Earnings
EPS
info
-$2.29
EPS estimate (current quarter)
info
-$0.58
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-123M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-0.28
52-week High
info
$11.14
52-week Low
info
$2.75
50-day moving average
info
$8.08
200-day moving average
info
$5.60
Short ratio
info
5.52
Short %
info
2.64%
Management effectiveness
ROE (TTM)
info
-53.28%
ROA (TTM)
info
-28.90%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
67M
Float
info
32.8M
Insiders %
info
0.09%
Institutions %
info
77.93%
Analyst Insights & forecasts
info

90% Buy

10% Hold

0% Sell

Based on information from 10 analysts.

Average price target

info
$23.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.48
-$0.37
-29.73%
Q1 • 25Missed
-$0.51
-$0.48
-6.25%
Q2 • 25Missed
-$0.57
-$0.51
-11.76%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-29M
-∞%
Q3 • 25
$0M
$-37.9M
-∞%
Q4 • 25
NaN%
30.66%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$246M
$44.9M
18.28%
Q3 • 25
$221M
$53.8M
24.27%
Q4 • 25
-9.81%
19.79%
32.81%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-25.6M
$1.4M
$-0.7M
$-26.3M
Q3 • 25
$-25M
$40.9M
$2M
$-25.4M
Q4 • 25
-2.62%
2,868.60%
-398.50%
-3.57%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a enGene Holdings Inc. Common Stock share?
Collapse

enGene Holdings Inc. Common Stock shares are currently traded for undefined per share.

How many shares does enGene Holdings Inc. Common Stock have?
Collapse

enGene Holdings Inc. Common Stock currently has 67M shares.

Does enGene Holdings Inc. Common Stock pay dividends?
Collapse

No, enGene Holdings Inc. Common Stock doesn't pay dividends.

What is enGene Holdings Inc. Common Stock 52 week high?
Collapse

enGene Holdings Inc. Common Stock 52 week high is $11.14.

What is enGene Holdings Inc. Common Stock 52 week low?
Collapse

enGene Holdings Inc. Common Stock 52 week low is $2.75.

What is the 200-day moving average of enGene Holdings Inc. Common Stock?
Collapse

enGene Holdings Inc. Common Stock 200-day moving average is $5.60.

Who is enGene Holdings Inc. Common Stock CEO?
Collapse

The CEO of enGene Holdings Inc. Common Stock is Ronald H. W. Cooper.

How many employees enGene Holdings Inc. Common Stock has?
Collapse

enGene Holdings Inc. Common Stock has 81 employees.

What is the market cap of enGene Holdings Inc. Common Stock?
Collapse

The market cap of enGene Holdings Inc. Common Stock is $618M.

What is the P/E of enGene Holdings Inc. Common Stock?
Collapse

The current P/E of enGene Holdings Inc. Common Stock is null.

What is the EPS of enGene Holdings Inc. Common Stock?
Collapse

The EPS of enGene Holdings Inc. Common Stock is -$2.29.

What is the PEG Ratio of enGene Holdings Inc. Common Stock?
Collapse

The PEG Ratio of enGene Holdings Inc. Common Stock is null.

What do analysts say about enGene Holdings Inc. Common Stock?
Collapse

According to the analysts enGene Holdings Inc. Common Stock is considered a buy.